The Breakthrough Device designation, instituted in 2016, is meant for products that are intended to address or diagnose life-threatening or irreversibly debilitating conditions. 110 devices have received the designation and 8 products have received approval through the regulatory pathway since the program has been introduced. Read more about this development here.
